Press Release: Toxys and Mutagentech Expand Access to Next-Generation Mutation Analysis Through Strategic Collaboration
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] PRESS RELEASE New collaboration brings ultra-sensitive SMM-seq technology to pharmaceutical, chemical and consumer product developers, enabling deeper insight into genetic safety assessment. Oegstgeest, The Netherlands – August 26, 2026 –Toxys, a global leader in innovative toxicology testing, and Mutagentech, a biotechnology company specialized in advanced genomic technologies,...
Toxys and Institute for In Vitro Sciences Expand Partnership to Advance Adoption of New Approach Methodologies in Genetic Toxicology
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] Leiden, The Netherlands and Gaithersburg, MD, USA — 17 July 2026 — Toxys and the Institute for In Vitro Sciences (IIVS) are pleased to announce an expanded strategic partnership aimed at accelerating the adoption of innovative in vitro methods for chemical safety assessment. Under...
ESTIV 2026 Highlights: Advancing NAMs Through Collaboration
[vc_row][vc_column][vc_column_text]ESTIV 2026 brought together researchers, regulators and industry experts from across the toxicology community to discuss the future of New Approach Methodologies (NAMs), with regulatory validation and implementation as central themes throughout the conference. Across scientific sessions, one message stood out: the field is rapidly progressing...
Press Release: OECD Publishes Test Guideline for ToxTracker®
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] PRESS RELEASE New OECD guideline enables regulatory use of ToxTracker® for mechanistic genotoxicity assessment Oegstgeest, The Netherlands – 6 July 2026 – Toxys, a leading innovator in toxicology solutions, announces the publication of OECD Test Guideline 446A for ToxTracker, its flagship genotoxicity testing platform. ToxTracker is...
Toxys Awarded ValNAM Grant to Validate ReproTracker
[vc_row][vc_column][vc_column_text] Bringing Animal-Free Developmental Toxicity Testing One Step Closer to Regulatory Acceptance Leiden, Netherlands – Toxys is proud to announce that it has been awarded funding through the ValNAM Call, a collaborative initiative launched by the German Federal Ministry of Research, Technology and Space (BMFTR) and ZonMw,...
Toxys and the Korean Institute of Toxicology Sign Memorandum of Understanding to Advance Collaboration in Genetic Toxicology
[vc_row][vc_column][vc_column_text]San Diego, CA – March 24, 2026 – Toxys and the Korean Institute of Toxicology (KIT) announce the signing of a Memorandum of Understanding (MoU). The signing took place at the San Diego Convention Center during the Society of Toxicology (SOT) 2026 Annual Meeting. This...
New Book Chapter: Genetic Toxicology Testing in Comprehensive Toxicology
[vc_row][vc_column width="1/6"][vc_single_image image="15845" img_size="full"][/vc_column][vc_column width="5/6"][vc_column_text]Present day genetic toxicity testing looks different than it did 20 years ago. The chapter dedicated to this topic in Comprehensive Toxicology has been revised with a focus on genotoxic mechanisms. In addition to identifying mutagenicity, aneugenicity, and clastogenicity, new approach...
Press Release: Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing
[vc_row][vc_column][vc_empty_space height="50px"][/vc_column][/vc_row][vc_row][vc_column width="2/3"][vc_column_text] PRESS RELEASE [/vc_column_text][/vc_column][vc_column width="1/6"][vc_single_image image="15778" img_size="full"][/vc_column][vc_column width="1/6"][vc_single_image image="15779" img_size="full"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text] Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing WILMINGTON, Mass. – October 8, 2025 – Charles River Laboratories International, Inc. (NYSE: CRL) and Toxys today announced a collaboration to...
Press Release: ToxTracker® Approved by OECD for Incorporation into Test Guideline Programme
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] PRESS RELEASE ToxTracker® Approved by OECD for Incorporation into Test Guideline Programme Oegstgeest, The Netherlands. September 4th, 2025 - Toxys, a leading innovator in animal-free toxicology solutions, announces that its flagship product, ToxTracker®, has been accepted into the Organization for Economic Co-operation and Development (OECD) Test Guidelines Programme....
ToxTracker EMP launches as a service for evaluating the genotoxic potential of N-nitrosamines
[vc_row][vc_column][vc_column_text]ToxTracker EMP (enhanced metabolization protocol) is a modified ToxTracker protocol to investigate the genotoxic potential of N-nitrosamines (NAs) in the presence of exogeneous metabolism. This enhanced protocol, which may be used across mammalian cell systems, greatly improves bioactivation of NAs and increases the sensitivity of...
